CRNX Stock-Based Compensation
Crinetics Pharmaceuticals Inc · Stock-Based Compensation
CRNX Stock-Based Compensation
Latest reported$98.98Mperiod ending
CRNX Stock-Based Comp ($270.00K → $98.98M)
Annual stock-based compensation
High-resolution chart · PNG
CRNX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 91,024,000 | |
| 69,386,000 | |
| 40,937,000 | |
| 28,268,000 | |
| 17,352,000 | |
| 10,427,000 | |
| 6,294,000 | |
| 2,320,000 | |
| 271,000 | |
| 270,000 |